NCT04376905View on ClinicalTrials.gov

Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19)

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

September 1, 2020

Study Completion Date

September 30, 2020

Conditions
COVID-19PneumoniaAcute Respiratory Distress Syndrome
Trial Locations (1)

34295

Uhmontpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT04376905 - Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19) | Biotech Hunter | Biotech Hunter